Garcia-Prats, A. J., Svensson, E. M., Winckler, J., Draper, H. R., Fairlie, L., van der Laan, L. E., . . . Hesseling, A. C. (2021). Pharmacokinetics and safety of high-dose rifampicin in children with TB: The Opti-Rif trial. Journal of antimicrobial chemotherapy, 76(12), 3237. https://doi.org/10.1093/jac/dkab336
Citace podle Chicago (17th ed.)Garcia-Prats, Anthony J., et al. "Pharmacokinetics and Safety of High-dose Rifampicin in Children with TB: The Opti-Rif Trial." Journal of Antimicrobial Chemotherapy 76, no. 12 (2021): 3237. https://doi.org/10.1093/jac/dkab336.
Citace podle MLA (9th ed.)Garcia-Prats, Anthony J., et al. "Pharmacokinetics and Safety of High-dose Rifampicin in Children with TB: The Opti-Rif Trial." Journal of Antimicrobial Chemotherapy, vol. 76, no. 12, 2021, p. 3237, https://doi.org/10.1093/jac/dkab336.